BioWorld Asia

Sep. 12, 2007

View Archived Issues

Swedish Study Finds Molecular Cause For Kidney Infections

Aptuit Paying $64M For Evotec Chemistry Unit

Antisoma's Lung Cancer Drug Repeats Strong Phase II Results

Biotech Fears Tough Restrictions From EU On Use of Primates

Nanobody Alliance With BI Could Net €200M For Ablynx

No Abstract Read More

FDA OKs TopoTarget's Totect For Extravasation Treatment

Other News To Note

BioAlliance Launches Loramyc; Pleased With Pricing Directive

Business and Academia Merge In UK-Australia Partnership

UK Opens Door to Work With Hybrid Embryos

LONDON - The UK regulator has agreed to the generation of human/animal hybrid embryos for stem cell research, paving the way for it to consider two applications for licenses to conduct such research. (BioWorld International) Read More

MediGene Gets $21M In Private Share Placement

Today's news in brief

BioWorld

BioWorld briefs for July 2, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 30, 2026

Black wavy lines forming an abstract sound wave.png

Deep brain stimulation from the shallows: tomorrow’s BCI technology?

BioWorld

Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...

AI-generated image for brain organoid neural research

CINP 2026: organoids reveal autism and addiction mechanisms

BioWorld Science

At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...

Handshake, businessmen holding dollar sign, lightbulb

Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal

BioWorld

A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...